We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Palantir’s Correction Eases as Investors Reassess Growth Potential Palantir Technologies Inc. (NASDAQ: PLTR) has faced a ...

Month Low. Apple Inc. (NASDAQ: AAPL) has been facing its worst week since March 2020, plunging over 12% as investor sentiment ...

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...

The overall returns have pretty much been the same, with HGER and SPY trailing the S&P 500 slightly - the index has no fund-manager expenses. But HGER has provided a smoother ride for investors, as it ...

Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

Eli Lilly's stock fell 4.58% following weak trial results from Novo Nordisk’s obesity drug, shaking investor confidence in ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Morgan Stanley analyst Terence Flynn notes that Novo Nordisk (NVO) reported CagriSema Phase 3 data in type two diabetes demonstrating weight ...